Lilly Launches Foundayo in the UK as NICE Review Continues
Eli Lilly and Company (NYSE:LLY) has launched Foundayo in the United Kingdom, making Britain the first European country where the company’s oral treatment for weight management...
Posts Tagged ‘NYSE:LLY’
Could Roche and Lilly’s Blood Test Make Alzheimer’s Assessment More Accessible?
Testing for Alzheimer’s-related brain changes has traditionally depended on procedures that can be expensive, invasive, or difficult to access.
Eli Lilly (LLY) Makes a $2.88 Billion Autoimmune Bet. What Could Go Right or Wrong?
Eli Lilly and Company (NYSE:LLY) has agreed to acquire privately held Merida Biosciences for up to $2.875 billion in cash, including an upfront payment and milestone-based payments...
Is OmniAb (OABI)’s Eli Lilly (LLY) Partnership a Game Changer for OABI?
On August 17, OmniAb, Inc.
Eli Lilly (LLY) Is Suing Six Companies Over an Unapproved Drug—Leaving Novo Nordisk (NVO) Clear in the GLP-1 Wars
On August 12, 2026, Eli Lilly and Company (NYSE:LLY) said that it filed six lawsuits against US companies it accuses of illegally selling black-market versions of retatrutide.
Is the Weight-Loss Drug Market Really a Winner-Take-All Fight Between Novo Nordisk (NVO) and Eli Lilly (LLY)?
On August 13, 2026, Novo Nordisk A/S (NYSE:NVO) CEO Mike Doustdar told Reuters that investors are underestimating how much the obesity drug market will fragment as new treatments...
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK
Drugmaker Bristol-Myers Squibb Company (NYSE:BMY) is putting real money behind its confidence in American manufacturing.
Can Eli Lilly Catch Novo Nordisk in the Oral GLP-1 Race?
The battle between Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) has so far been defined by blockbuster injectable weight loss drugs.
UnitedHealth Group (UNH) vs. Eli Lilly and Company (LLY): Which Healthcare Stock Offers the Better Dividend?
UnitedHealth Group Incorporated (NYSE:UNH) and Eli Lilly and Company (NYSE:LLY) both have respectable dividend records, but the two companies are at different stages of their ...
Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start
On August 10, Eli Lilly and Company (NYSE:LLY)'s weight-loss pill Foundayo won approval in the UK, becoming the first country in Europe to clear the drug for both weight management...
Eli Lilly’s (LLY) Growth Story Keeps Adding Chapters
On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days since have brought even more good news.
Eli Lilly’s Weight-Loss Pill Just Got Its First Foothold in Europe
Eli Lilly and Company (NYSE:LLY) cleared a notable regulatory hurdle on August 10, when Britain's drug regulator authorized the company's oral GLP-1 drug orforglipron, becoming...
Can Veeva Systems Inc. (VEEV)’s AI Platform Keep Pace With Eli Lilly and Company (LLY)’s Explosive Growth
On August 11, Veeva Systems Inc. (NYSE:VEEV) announced that Eli Lilly and Company (NYSE:LLY) committed to deploying Veeva Vault CRM globally.
Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?
The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom.
Eli Lilly vs. Novo Nordisk: Which Company Is Better Positioned for America’s New Drug Manufacturing Policies?
For years, investors have viewed Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) through one lens: the race to dominate the booming obesity-drug market.
Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?
The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution.
Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY
During the August 6 episode of CNBC’s Mad Money, Jim Cramer pointed to a growing sector rotation as portfolio managers look for innovation outside the mega-cap technology space...
Eli Lilly (LLY) Posts Blowout Growth And Raises Its Outlook
Eli Lilly (NYSE:LLY) delivered a quarter that forced Wall Street to catch up to its own numbers.
Earnings Standouts: 52 Stocks Outperforming Wall Street Estimates
Research by the Bank for International Settlements said that equity markets tend to already price in earnings expectations well before official results are announced.
Is Eli Lilly (LLY) Still the Undisputed Leader in the $150 Billion Obesity Drug Market?
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Pfizer Inc. (PFE) vs. Eli Lilly and Company (LLY): The Growth vs. Value Play in Pharma
Pfizer (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) offer unique divergent investment opportunities in the pharmaceutical industry.
Jim Cramer Wants Novo Nordisk A/S (NYSE:NVO) To Compete With Eli Lilly In The Market & Not The Courts
Novo Nordisk A/S (NYSE:NVO) was at the center of media coverage as it sued rival weight loss drug manufacturer Eli Lilly on Tuesday.
Claude AI Disagrees With President Trump on Eli Lilly (LLY)
President Donald Trump recently praised Eli Lily at a public event and called it "a great company” and highlighted its planned $3.5 billion investment for a manufacturing plant...
Eli Lilly and Company (LLY) Fell on Regulatory And Pricing Policy Challenges
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q1 2026 investor letter.
Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks
In this article, we will highlight Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks.
10 Stocks That Will Make You Rich Over the Next 3 Years
In this article, we will look at the 10 Stocks That Will Make You Rich Over the Next 3 Years.
Eli Lilly (LLY) and BioArctic AB Enter into Research and Collaboration Agreement
Eli Lilly and Company (NYSE:LLY) is one of the top trending US stocks to buy now.
Here’s What the Street Thinks About Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE:LLY) is one of the safe stocks for beginners to buy in 2026. Eli Lilly and Company (NYSE:LLY) received a rating update from Leerink on June 25.
10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds
In this article, we will discuss: 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds.
15 Safe Stocks for Beginners to Buy in 2026
In this article, we will look at the 15 Safe Stocks for Beginners to Buy in 2026.
10 Best Stocks For Beginners to Buy Now
In this article, we will discuss the 10 Best Stocks For Beginners to Buy Now.
10 Trending US Stocks to Buy Now
In this article, we will look at the 10 Trending US Stocks to Buy Now.
10 High Growth Stocks to Buy Right Now
In this article, we will discuss the 10 High Growth Stocks to Buy Right Now.
10 Reliable Dividend Stocks to Buy for Long-Term Investors
In this article, we will take a look at the 10 Reliable Dividend Stocks to Buy for Long-Term Investors.
Is Eli Lilly and Company (LLY) Strengthening Its Pain Management Strategy With New Biotech Acquisition?
We recently compiled a list of the 10 Best Weight Loss Drug Stocks to Buy in 2026. Eli Lilly and Company (NYSE:LLY) is one of the best weight loss drugs on this list.
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On
In this article, we will discuss: 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On.
10 Best Weight Loss Drug Stocks to Buy in 2026
In this article, we will be taking a look at the 10 Best Weight Loss Drug Stocks to Buy in 2026.
7 Best Longevity and Anti-Aging Stocks to Buy
In this article, we will discuss 7 Best Longevity and Anti-Aging Stocks to Buy.
10 Stocks with Best Earnings Growth for the Next 3 Years
In this article, we will take a look at the stocks with the best earnings growth for the next 3 years.
Jim Cramer’s 29 Stock Calls and Space Players Worth Watching Like SpaceX and Rocket Lab
In this article, we will look at Jim Cramer’s stock calls on Mad Money, as he highlighted worthy space players and reviewed several of this year’s IPOs.
10 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates
In this article, we will discuss the 10 Best Growth Stocks to Buy According to Billionaire Ray Dalio's Bridgewater Associates.
Billionaire Ken Fisher’s Top 12 High-Growth Stock Picks
In this article, we will discuss Billionaire Ken Fisher's Top 12 High-Growth Stock Picks.
12 Best Growth Stocks Trading in Oversold Territory
In this article, we will discuss the 12 Best Growth Stocks Trading in Oversold Territory.
10 Most Profitable Blue Chip Stocks to Buy According to Hedge Funds
In this piece, we discuss the 10 Most Profitable Blue Chip Stocks to Buy According to Hedge Funds. Strong U.S.
7 Best Compounder Stocks to Buy Now
In this article, we will look at the 7 Best Compounder Stocks to Buy Now.
Jim Cramer Didn’t Hold Back On SpaceX’s IPO & Discussed These 12 Stocks
In this article, we will discuss: Jim Cramer Didn't Hold Back On SpaceX's IPO & Discussed These 12 Stocks.
10 Good Stocks to Invest In Now
In this article, we will look at the 10 Good Stocks to Invest In Now. On June 10, Tom Lee appeared on a CNBC Television interview to discuss the latest market moves.
10 Best Forever Stocks to Buy According to Analysts
In this article, we will discuss the 10 Best Forever Stocks to Buy According to Analysts.
10 Best Dividend Stocks to Buy According to D. E. Shaw
In this article, we will take a look at the 10 Best Dividend Stocks to Buy According to D. E. Shaw. D. E. Shaw was founded by David E. Shaw in 1988.
10 Most Profitable Growth Stocks to Buy
In this article, we will discuss the 10 Most Profitable Growth Stocks to Buy.
Hedge Fund Resource Center
